GlassScriptPhysician profile
John C Cook
NPI 1467443580
$705.78
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $146 · 2021: $117 · 2023: $38.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $153.28 | 2019-2021 | |
| Glaxosmithkline, LLC. | $103.91 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $63.78 | 2019 | |
| Amarin Pharma, INC. | $61.52 | 2019-2020 | |
| Amgen INC. | $49.97 | 2019-2020 | |
| Lilly USA, LLC | $39.97 | 2019-2023 | Mounjaro |
| Radius Health, INC. | $36.60 | 2019-2020 | |
| Inspire Medical Systems, INC. | $23.87 | 2023 | Inspire |
| Janssen Pharmaceuticals, INC | $23.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $23.41 | 2019 | |
| Merck Sharp & Dohme LLC | $22.65 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.41 | 2019 | |
| Astellas Pharma US INC | $17.77 | 2019 | |
| Qiagen, LLC | $17.53 | 2019 | |
| Sunovion Pharmaceuticals INC. | $17.20 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.